Form 4 Tracker
PTC THERAPEUTICS, INC.
PTCT

44 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 24, 2026Jun 26 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
5,323$85.03$452.6K60,137(D)

View →

Jun 26, 2026Jun 26 7:29 PMAlmstead Neil Gregory
Proposed Sale
8,130$85.26$693.1K—

View →

Jun 25, 2026Jun 25 8:16 PMAlmstead Neil Gregory
Proposed Sale
20,960$85.97$1.8M—

View →

Jun 22, 2026Jun 24 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
23,749$80.90$1.9M60,137(D)

View →

Jun 24, 2026Jun 24 8:11 PMAlmstead Neil Gregory
Proposed Sale
5,323$85.03$452.6K—

View →

Jun 17, 2026Jun 22 9:20 PMChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER
Sale
19,686$75.56$1.5M70,199(D)

View →

Jun 17, 2026Jun 22 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
10,462$78.65$822.9K105,272(D)

View →

Jun 22, 2026Jun 22 8:25 PMAlmstead Neil Gregory
Proposed Sale
23,749$80.91$1.9M—

View →

Jun 17, 2026Jun 17 8:09 PMBoulding Mark Elliott
Proposed Sale
10,522$78.65$827.6K—

View →

Jun 17, 2026Jun 17 1:39 PMUtter Christine Marie
Proposed Sale
19,686$75.56$1.5M—

View →

Jun 10, 2026Jun 12 9:30 PMEric PauwelsCHIEF BUSINESS OFFICER
Sale
21,277$75.00$1.6M73,411(D)

View →

Jun 10, 2026Jun 10 4:51 PMPauwels Eric
Proposed Sale
21,277$75.00$1.6M—

View →

May 15, 2026May 19 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
2,812$72.18$203.0K105,212(D)

View →

May 14, 2026May 15 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
12,572$72.95$917.2K393,998(D)

View →

May 15, 2026May 15 2:06 PMBoulding Mark Elliott
Proposed Sale
2,812$72.45$203.7K—

View →

May 14, 2026May 14 7:09 PMKlein Matthew B.
Proposed Sale
2,572$72.46$186.4K—

View →

May 14, 2026May 14 4:43 PMKlein Matthew B.
Proposed Sale
10,000$73.08$730.8K—

View →

May 8, 2026May 12 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
3,540$78.97$279.6K105,212(D)

View →

May 8, 2026May 8 8:15 PMBoulding Mark Elliott
Proposed Sale
3,540$78.97$279.6K—

View →

Apr 21, 2026Apr 23 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
2,850$70.91$202.1K394,070(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,265$39.426,798(D)

View →

Mar 24, 2026Mar 26 11:41 PMJessica Caroline ChutterDirector
Grant/Award
6,371$64.542,896(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Option Exercise
15,167$33.630(D)

View →

Feb 17, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,813$25.6922,501(D)

View →

← Previous

Page 2 of 2